808MO Value of early post-treatment FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T cell therapy von Mirshahvalad, S.A., Kohan, A., Kulanthaivelu, R., Chin, Y., Chen, C., Hodgson, D., Kridel, R., Bhella, S., Metser, U., Veit-Haibach, P.

Volltext